LAVENTAIR ELLIPTA

Medicinal product

(Invented) name

LAVENTAIR ELLIPTA

Active substance (s)

Umeklidinas/Vilanterolas

Strength

55 µg/22 µg

Pharmaceutical form

įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AL03, Vilanterol and umeclidinium bromide

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

2014-05-08

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Inhalation powder, pre-dispensed	1 dozėje
Umeklidinas	55 µg
Vilanterolas	22 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
59194	73418	1073418	inhaliatorius	7 dozės N1		Receptinis	EU/1/13/899/001	Netiekiama	-	-	No	-	-
59195	73419	1073419	inhaliatorius	30 dozių N1		Receptinis	EU/1/13/899/002	Netiekiama	-	-	No	-	-
59196	73420	1073420	inhaliatorius	90 dozių (N3x30 dozių)		Receptinis	EU/1/13/899/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-05-08	Registruotas